Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-048785

AERIE PHARMACEUTICALS INC · AERI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas A Mitro
Officer — President and COO
Period of report
Aug 27, 2018
Accepted (ET)
Aug 29, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 27, 2018M182,668$3.15A234,147D
Common StockAug 27, 2018M7,332$3.15A241,479D
Common StockF1,F2Aug 27, 2018S189,549$60.2667D51,930D
Common StockF2,F3Aug 27, 2018S451$61.0051D51,479D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Option (Right to Buy)$3.15Aug 27, 2018M182,668DAug 5, 2017Aug 26, 2023Common Stock182,668126,984D
Option (Right to Buy)$3.15Aug 27, 2018M7,332DAug 5, 2017Sep 12, 2023Common Stock7,33263,498D

Explanation of responses